Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Visit NurExone Biologic Inc.

NurExone is aiming to revolutionize recovery from nervous system injuries by regenerating and rewiring of neurons.



Bullboard - Investor Discussion Forum NurExone Biologic Inc. V.NRX

Alternate Symbol(s):  NRXBF

NurExone Biologic Inc. is a pharmaceutical company. The Company is engaged in developing a platform for biologically guided exosome-based therapies to be delivered, minimally invasive, to patients who have suffered central nervous system injuries. The Company’s first product, ExoPTEN for acute spinal cord injury, uses exosomes loaded with a specific and proprietary sIRNA sequence as the active... see more

TSXV:NRX - Post Discussion

NurExone Biologic Inc. > Is This Biotech Now Poised For It's First Clinical Trials?
View:
Post by javaman12 on Jan 11, 2025 10:36pm

Is This Biotech Now Poised For It's First Clinical Trials?

Imagine if it were possible to cure most neurological damage (like an accidental spinal paralysis, stroke or damage to the eye) with a simple squirt in the nose by the use of a simple nasal inhaler!

Our bodies are completely entwined by many different complex systems of nerves. These biological tissues most define who we are as people. The healthiest of nervous systems makes for the most complete and socially interactive persons. 

Such non-invasive (nasal sprays) drug delivery systems are already commonly in use for effectively treating symptoms of allergic nasal congestion. They can be easily obtained over the counter or by prescription from your family doctor.

NurExone is on the path to provide a simple and cost effective treatment for even the most complex of nerve damage disorders. 

With NurExone's recent acquisition of a master cell bank, the company is now set to begin its first clinical trials. Once the market becomes more aware of the significance of this very last bit of public information, then the share price should start to rise fairly quickly. 

Clinical trials are costly endeavors. But what this company now offers the world is a staggering potential for cure!

I expect that a partnership with some big pharmaceutical manufacturer may soon be announced!

Even the new Trump anti-vax medical advisory team would likely jump at the chance to whole heartedly support a radical new idea of providing a cure for many different complex disorders of the human body by using a simple squirt of some drug into the nose!

They might even jump on board this new kind of bandwagon by pushing some new grant money quickly in this company's direction! Certainly, an Israeli biotech company might be given some preferential treatment by a new Trump administration. They do look more favourably and fondly towards this tiny, but mostly beloved, Middle Eastern country! 

But many Middle Eastern wealth funds are also seeking to diversify their holdings! They are even keener to compete!

And so are many European nations, also just as eager, who hate seeing so many of their population, wasting away their lives, sitting needlessly in wheelchairs, perhaps lost sadly in self-destructive thinking!

Suicide has become an acceptable social norm in many different nations! Why should this be?

Why delay such a project? Why not even promote it? Why not promote the idea of ever better human health? Wouldn't it be better to live a longer, more fulfilled and productive life if its quality was substantially better?

Why should nursing homes be so full of very unhappy and lost human souls facing a very cruel and unhappy end?

Shouldn't a life of a mere hundred years become the norm in a few short years from now? That's an idea almost biblical in proportions! Are we almost there? Isn't a new day about to dawn?

Perhaps even fewer clinical trials might have to be done when such a simple drug delivery system is used that quickly remediates any issue of health or even provides a cure?

From where, will the necessary research funding come? Just tap on the right door! They will come  a running!

Stock analysts suggest that this company should already be worth 2 to 3 dollars Canadian per share. Why is it trading at only 68 cents?

The analysts have done their due dilligence while most of the market has slumbered.

What will happen to the share price for this company once a partnership is announced or the market starts to wake up a little bit more? What happens to the share price when the final trials are finished?

Can you stretch your neck to look, all that high?

Perhaps there is a very good reason that so many of this company's shareholders have stubbornly refused to sell?

I was able to purchase a few shares on Friday but I wish that I could have bought more!

https://nurexone.com/investors/#Analyst_Coverage

https://s27.q4cdn.com/906368049/files/News/2024/Zacks_SCR_Research_12092024_NRXBF_Sorensen.pdf

https://nurexone.com/wp-content/uploads/2024/10/Zacks_SCR_Research_10022024_NRXBF_Sorensen.pdf

The best of miracles should come by the touch of the master's hand or from the grasp of his robe!

But whatever the source of the healing, let it be a simpler one, a foundational principal for healing that comes with a much better and widespread acceptance, rather than just by some simpler faith or questionable system of belief!

             Take that to any social media site! Then promote this kind of goodwill for all to see!

                                               What doesn't divide us, keeps us together!

                               NurExone is looking for more investment capital to finish the job.

                                                       This shouldn't take too long!

                    Yeah I know that I bought too few shares. But at least I did my small little part!

                                                                  Do yours too!

                                                                All the best! Java


Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.NRX



Investor Presentation

View the Presentation

Investment Opportunity

NurExone operates according to two business lines – Development of a first exosome-based therapy for acute Spinal Cord Injuries (SCI).

In parallel, the company is monetizing its proprietary ExoTherapy platform through licensing to the global biopharmaceutical industry to deliver therapies for other diseases and indications.

The company’s first product, ExoPTEN, for acute spinal cord injury, has been granted Orphan Drug Designation by the FDA.



The Watchlist

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Why NurExone??

The Ultimate Drug Delivery System

The Beginning of NurExone

Facebook

Contact Us

Dr. Lior Shaltiel
Chief Executive Officer and Director
Phone: +972-52-4803034
Email: info@nurexone.com

Thesis Capital Inc.
Investment Relation - Canada
Phone: +1 905-347-5569
Email: IR@nurexone.com

Dr. Eva Reuter Investment Relation - Germany
Phone: +49-69-1532-5857
Email: e.reuter@dr-reuter.eu